In line with the findings of the discovery analysis, the VGF [585–594] peptide showed a trend to downregulation in all psychiatric disorders in comparison to the control group in the MRM cohort.
← all excerpts
Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder.
1
—
—